1. Home
  2. MARPS vs RDHL Comparison

MARPS vs RDHL Comparison

Compare MARPS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MARPS
  • RDHL
  • Stock Information
  • Founded
  • MARPS 1956
  • RDHL 2009
  • Country
  • MARPS United States
  • RDHL Israel
  • Employees
  • MARPS N/A
  • RDHL N/A
  • Industry
  • MARPS Oil & Gas Production
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MARPS Energy
  • RDHL Health Care
  • Exchange
  • MARPS Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • MARPS 8.7M
  • RDHL 8.2M
  • IPO Year
  • MARPS N/A
  • RDHL N/A
  • Fundamental
  • Price
  • MARPS $4.03
  • RDHL $5.23
  • Analyst Decision
  • MARPS
  • RDHL
  • Analyst Count
  • MARPS 0
  • RDHL 0
  • Target Price
  • MARPS N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • MARPS 16.3K
  • RDHL 10.1K
  • Earning Date
  • MARPS 01-01-0001
  • RDHL 04-07-2025
  • Dividend Yield
  • MARPS 8.81%
  • RDHL N/A
  • EPS Growth
  • MARPS N/A
  • RDHL N/A
  • EPS
  • MARPS 0.36
  • RDHL N/A
  • Revenue
  • MARPS $1,042,513.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • MARPS N/A
  • RDHL $224.90
  • Revenue Next Year
  • MARPS N/A
  • RDHL $82.69
  • P/E Ratio
  • MARPS $11.08
  • RDHL N/A
  • Revenue Growth
  • MARPS N/A
  • RDHL N/A
  • 52 Week Low
  • MARPS $3.76
  • RDHL $5.20
  • 52 Week High
  • MARPS $6.50
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • MARPS 49.04
  • RDHL 31.92
  • Support Level
  • MARPS $3.81
  • RDHL $5.52
  • Resistance Level
  • MARPS $4.09
  • RDHL $5.71
  • Average True Range (ATR)
  • MARPS 0.15
  • RDHL 0.27
  • MACD
  • MARPS -0.01
  • RDHL -0.04
  • Stochastic Oscillator
  • MARPS 56.92
  • RDHL 2.38

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: